Publication:
A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib

dc.contributor.authorsIlhan, Osman; Seval, Guldane Cengiz; Bozdag, Sinem Civriz; Deveci, Burak; Pehlivan, Mustafa; Kaynar, Leylagul; Yavasoglu, Irfan; Bekoz, Huseyin; Hindilerden, Ipek Yonal; Yegin, Zeynep Arzu; Dagdas, Simten; Avsar, Ayse; Ozkan, Atilla Hasan; Tuglular, Tulin Firat; Goker, Hakan; Golbas, Zafer
dc.date.accessioned2022-03-10T18:01:08Z
dc.date.accessioned2026-01-11T11:15:00Z
dc.date.available2022-03-10T18:01:08Z
dc.date.issued2020
dc.identifier.doidoiWOS:000600556201186
dc.identifier.eissn1476-5365
dc.identifier.issn0268-3369
dc.identifier.urihttps://hdl.handle.net/11424/222341
dc.identifier.wosWOS:000600556201186
dc.language.isoeng
dc.publisherSPRINGERNATURE
dc.relation.ispartofBONE MARROW TRANSPLANTATION
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleA New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPage330
oaire.citation.issueSUPPL 1
oaire.citation.startPage329
oaire.citation.titleBONE MARROW TRANSPLANTATION
oaire.citation.volume55

Files